drugset / Trial / NCT00004999
Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients
Double-blindTreatment
Summary
The purpose of this study is to look at the effectiveness of giving a new anti-HIV drug (AG1549) plus Viracept (nelfinavir) plus Combivir (a tablet containing zidovudine plus lamivudine) to HIV-infected patients who are not taking anti-HIV drugs.
Timeline
- Start
- 1999-08
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capravirine | Small molecule | — | — |
| Background | Lamivudine | Other / unclassified | — | — |
| Background | Nelfinavir | Other / unclassified | — | — |
| Background | Zidovudine | Small molecule | — | — |